|
by Chris Chiappinelli, MA Editorial Staff Posted on Thursday, June 19, 2008 4:17:32 PM   | Abstract: | Pharmaceutical companies are among the most heavily regulated in the world, with quality control high on the task list, but what happens when they lose control? |
How do you manage the quality of your products when companies outside your control are manufacturing them? That's the dilemma pharmaceutical companies face as the sale of counterfeit drugs grows, aided in part by an insidious brand of spam proliferating across the Internet.
In a twisted intersection of traditional manufacturing and the digital economy, purveyors of e-mail spam, including the prolific Storm virus, have adopted the business techniques of legitimate businesses to deliver knockoff prescription drugs.
According to a recent Los Angeles Times article:
[Click to continue] |